- Home
- OTLK vs HKIT Comparison
OTLK vs HKIT Comparison
Compare OTLK & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- HKIT
- Stock Information
- Founded
- OTLK 2010
- HKIT 1996
- Country
- OTLK United States
- HKIT China
- Employees
- OTLK N/A
- HKIT N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- HKIT Computer Software: Prepackaged Software
- Sector
- OTLK Health Care
- HKIT Technology
- Exchange
- OTLK Nasdaq
- HKIT Nasdaq
- Market Cap
- OTLK 48.3M
- HKIT 39.8M
- IPO Year
- OTLK 2016
- HKIT 2023
- Fundamental
- Price
- OTLK $1.09
- HKIT $1.75
- Analyst Decision
- OTLK Buy
- HKIT
- Analyst Count
- OTLK 5
- HKIT 0
- Target Price
- OTLK $8.50
- HKIT N/A
- AVG Volume (30 Days)
- OTLK 8.2M
- HKIT 42.8K
- Earning Date
- OTLK 08-14-2025
- HKIT 10-27-2025
- Dividend Yield
- OTLK N/A
- HKIT N/A
- EPS Growth
- OTLK N/A
- HKIT N/A
- EPS
- OTLK N/A
- HKIT N/A
- Revenue
- OTLK $1,505,322.00
- HKIT $2,904,950.00
- Revenue This Year
- OTLK N/A
- HKIT N/A
- Revenue Next Year
- OTLK $484.88
- HKIT N/A
- P/E Ratio
- OTLK N/A
- HKIT N/A
- Revenue Growth
- OTLK N/A
- HKIT N/A
- 52 Week Low
- OTLK $0.79
- HKIT $1.15
- 52 Week High
- OTLK $7.26
- HKIT $2.08
- Technical
- Relative Strength Index (RSI)
- OTLK 37.49
- HKIT 58.27
- Support Level
- OTLK $1.02
- HKIT $1.48
- Resistance Level
- OTLK $1.19
- HKIT $2.08
- Average True Range (ATR)
- OTLK 0.22
- HKIT 0.11
- MACD
- OTLK -0.04
- HKIT 0.03
- Stochastic Oscillator
- OTLK 11.18
- HKIT 39.34
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.